Scott Chouinard
Comptroller/Controller/Auditor chez FORRESTER RESEARCH, INC.
Fortune : 171 919 $ au 31/03/2024
Profil
Scott R.
Chouinard is currently working as the Treasurer & Chief Accounting Officer at Forrester Research, Inc. He previously worked as a Controller at EPIX Pharmaceuticals, Inc. Mr. Chouinard completed his undergraduate degree at Merrimack College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FORRESTER RESEARCH, INC.
0,04% | 01/03/2024 | 7 974 ( 0,04% ) | 171 919 $ | 31/03/2024 |
Postes actifs de Scott Chouinard
| Sociétés | Poste | Début |
|---|---|---|
| FORRESTER RESEARCH, INC. | Comptroller/Controller/Auditor | 19/11/2009 |
Anciens postes connus de Scott Chouinard
| Sociétés | Poste | Fin |
|---|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Comptroller/Controller/Auditor | - |
Formation de Scott Chouinard
| Merrimack College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FORRESTER RESEARCH, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
